T-cell responses and therapies against SARS-CoV-2 infection
Salman M Toor, Reem Saleh, Varun Sasidharan Nair, Rowaida Z Taha, Eyad Elkord
Immunology | WILEY | Published : 2020
Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, a novel coronavirus strain. Some studies suggest that COVID-19 could be an immune-related disease, and failure of effective immune responses in initial stages of viral infection could contribute to systemic inflammation and tissue damage, leading to worse disease outcomes. T cells can act as a double-edge sword with both pro- and anti-roles in the progression of COVID-19. Thus, better understanding of their roles in immune responses to SARS-CoV-2 infection is crucial. T cells primarily react to the spike protein on the coronavirus to initiate antiviral immunity; however, T-cell responses can be suboptimal, impaired or excessive in ..View full abstract
Open Access funding was provided by the Qatar National Library.